Page last updated: 2024-12-05

cyclopropanecarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyclopropanecarboxylic acid is a cyclic organic compound with a carboxyl group attached to a cyclopropane ring. It is a colorless liquid with a pungent odor. Cyclopropanecarboxylic acid is a versatile building block in organic synthesis, and its derivatives have been explored for their potential applications in medicine and agriculture. It is typically synthesized by the reaction of cyclopropane with carbon dioxide in the presence of a base. Cyclopropanecarboxylic acid is known to exhibit antibacterial activity against some Gram-positive bacteria. It has also been studied for its potential as a precursor to other bioactive compounds. The unique three-membered ring structure of cyclopropanecarboxylic acid gives it unusual reactivity and makes it a subject of interest for theoretical studies.'

cyclopropanecarboxylic acid: 0 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15655
CHEMBL ID4649900
CHEBI ID23500
MeSH IDM0065279

Synonyms (53)

Synonym
CHEBI:23500
cpc-acid
ai3-30542
einecs 217-162-5
brn 0969839
nsc 1112
cyclopropane-carboxylic acid
inchi=1/c4h6o2/c5-4(6)3-1-2-3/h3h,1-2h2,(h,5,6
wln: l3tj avq
1759-53-1
cyclopropylcarboxylic acid
nsc-1112
nsc1112
carboxycyclopropane
cyclopropionic acid
cyclopropanecarboxylic acid
cyclopropanecarboxylic acid, 95%
cyclopropane carboxylic acid
AKOS000119770
A812135
unii-008803351s
008803351s ,
4-09-00-00003 (beilstein handbook reference)
cyclopropanecarboxylicacid
STL168574
FT-0624283
AM83282
cyclopropancarboxylic acid
cyclopropan carboxylic acid
cyclopropyl-carboxylic acid
cyclopropyl carboxylic acid
2-cyclopropanecarboxylic acid
Q-200907
89924-82-3
cyclopropylmethanoic acid
cyclpropanecarboxylic acid
mfcd00001287
DTXSID1040665
F2191-0028
cyclopropanecarboxylic acid, purum, >=98.0% (t)
8 olaparib impurity 8
CS-W018339
cyclopropyl formic acid
Q2317381
cyclopropane-1-d1-carboxylic acid
STR00627
cyclopropane-2,2,3,3-d4-carboxylic acid
zpj ,
EN300-19510
CHEMBL4649900
HY-Y0001
ou0 ,
OTO ,

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Rats dosed orally which [carboxyl-14C]cyclopropanecarboxylic acid (or its hexadecyl ester) retain radioactivity in tissue as novel triacylglycerols."( Cyclopropanecarboxylic acid: chain elongation to omega-cyclopropyl fatty acids by mammals and plants.
Quistad, GB; Schooley, DA; Staiger, LE, 1978
)
1.97
" Sprague-Dawley rats were dosed days with cyclopropane carboxylic acid (CPCA) a short-chain fatty acid that can induce microvesicular steatosis, and with butyrate, a short chain fatty acid that served as a negative control."( Microvesicular steatosis induced by a short chain fatty acid: effects on mitochondrial function and correlation with gene expression.
Ciurlionis, R; Helgren, M; Jolly, RA; Morfitt, D; Patterson, R; Ulrich, RG; Waring, JF,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
cyclopropanesCyclopropane and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1750491Reduction of propionyl-CoA in human hepatocytes derived from propionic acidemia patient at 100 uM pretreated for 30 mins followed by 13C-isoleucine addition and measured after 1 hr by MS/MS analysis relative to control2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
AID1750492Reduction of propionyl-CoA in human hepatocytes derived from propionic acidemia patient pretreated for 30 mins followed by 13C-isoleucine addition and measured after 1 hr by MS/MS analysis2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (11.90)18.7374
1990's6 (14.29)18.2507
2000's18 (42.86)29.6817
2010's10 (23.81)24.3611
2020's3 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.39 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index56.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]